Newsletter Subscription

Enter Name and Email

NeuroAct Communication - Newsletter - December 2010


Expertise in Neuropharmacology





End-of-year News

NeuroAct Communication is pleased to celebrate its first 6 months of busy activity:

  • Consulting assignments were conducted in Europe and the USA (read more).
  • Adrian Newman-Tancredi gave lectures at the Polish Psychiatry Association in Poznan and at the ECNP meeting in Amsterdam
    (read more).
  • Contacts were maintained with academic centres (read more).

Many thanks to all those that have helped
 in these achievements !









NeuroAct Communication is an independent consulting service founded by Adrian Newman-Tancredi Ph.D.,
an experienced pharmaceutical industry professional.

Find out more about Adrian in his Executive Profile.

NeuroAct Communication advises lifescience companies and funding agencies on neuropharmacology and central nervous system drug discovery programs.
Find out about our Consulting Services.




NeuroAct Communication wishes you 
happy holidays, and much success in 2011



Scientific Communication

Adrian Newman-Tancredi has extensive experience of publication in peer-reviewed journals (read more).
His specialty areas include the following:
  • Pharmacology of novel antipsychotics, such as aripiprazole and lurasidone.
    (watch Webcast)
  • Mechanisms of CNS serotonergic function, particularly concerning "biased agonism" (or "functional selectivity") at 5-HT1A receptors (read more).
To find out how Adrian can assist you in scientific communication contact.